Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for cardiometabolic diseases, including a thoughtful discussion of cellular and molecular mechanisms involved in the progression of metabolic risks, approaches for the early detection, and robust management of metabolic risks. Written by a team of expert contributors, this book is useful reading for researchers and clinicians interested on recent advances in etiology of cardiometabolic diseases, the latest noninvasive approaches for diagnosis, risk assessment tools, therapeutic strategies, and also aspects of prevention of cardiometabolic diseases.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
PrefaceForeword
I. Cardiometabolic Diseases
1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the Management of Risks.
2. The Chennai Urban Rural Epidemiology Study (CURES) - A Compendium of type 2 diabetes in urban Asian Indians: Lessons Learnt
3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study
4. Burden of cardiometabolic syndrome in children.
5. Diabetes care program with limited resources
6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes
7. Understanding double burden of malnutrition from a DOHaD perspective: Review of Mysore Cohorts
8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades of science, medicine, creativity and empathy (Samatvam India model)
9. Pathophysiology of Cardiorenal Syndrome
10. Evidence of Clinical Trials of Cardiac Outcomes on Renal Disease
II. CMDs: Cellular Mechanisms
11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases
12. Insulin is a cytoprotective molecule
13. Galectin-3 and its associated molecular partners in the emergence and progression of cardiometabolic disorders
14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA
15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational Research
16. Are Southeast Asians Cushingoid? A molecular explanation for the high incidence of metabolic
syndrome
17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms
18. Why is exercise beneficial?
III. Risk Factors and Prevention
19. Hypothyroidism, Diabetes and Cardiovascular disease
20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes why fat is not the enemy in Cardiometabolic disease
21. Risk Factors for Ischemic Stroke
22. Blood pressure lowering in kidney disease
23. Diabetic Peripheral Vascular Disease.
24. Limb salvage among people with Diabetes.
25. The role of Blood Viscosity in Health and Disease
26. Hypertension and Acute coronary Syndromes
27. Hypertension and Stroke: An Update
28. Prevention of Childhood Obesity and Diabetes : An Indian Context
29. Screening of cardiovascular risk in school children and adolescents
30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases
31. Type 1 diabetes risk factors and prevention
32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned and the Way Forward
33. Measurement of Carotid Plaque Burden.
34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac Arrest Survival and Neurological Outcome
35. Secondary Stroke Prevention
36. Acute Ischemic Stroke: Diagnosis and Endovascular Management
37. Cardiometabolic Diseases Recent Advance in Antithrombotic and Thrombolytic Therapies
38. Management of Cardio-Metabolic Diseases: A Clinician's Perspective
39. Prevention of Cardiovascular Diseases From Science to Public Health Action
Authors
Gundu H. R. Rao Emeritus Professor, Laboratory Medicine and Pathology, University of Minnesota, USA. Emeritus Professor, Dr Gundu H. R. Rao has spent forty years as a faculty member of Laboratory Medicine and Pathology at the University of Minnesota. He was the Director of Thrombosis Research at the Lillehei Heart Institute and adjunct faculty of the Institute for Engineering Medicine as well as Anesthesiology. For four decades, he conducted research on morphology, ultrastructure, biochemistry, physiology, and pharmacology of blood platelets. During these years of research, he presented his work at various national and international conferences as well as published his work in over 300 peer reviewed journals. In early 1990, he obtained a research grant from the International Society on Thrombosis and Hemostasis (ISTH, USA), and started a professional society, 'South Asian Society on Atherosclerosis and Thrombosis' at the University of Minnesota. He organized international conferences on topics associated with thrombosis and hemostasis in India every other year from 1994. He also has edited and published books on topics related to this area of public interest. Undurti N. Das Internal Medicine from Osmania Medical College, Hyderabad, India; Chairman and Research Director, UND Life Sciences LLC, USA.Undurti N. Das is an M.D. in Internal Medicine from Osmania Medical College, Hyderabad, India; a Fellow of the National Academy of Medical Sciences, India, and Shanti Swaroop Bhatnagar prize awardee. Apart from clinical work, he is researching the role of polyunsaturated fatty acids, cytokines, nitric oxide, free radicals, and anti-oxidants in cancer, inflammation, metabolic syndrome, schizophrenia, sepsis, rheumatological conditions and autisms. His current interests include the epidemiological and molecular aspects of autism, diabetes mellitus, hypertension, cardiovascular diseases and metabolic syndrome. Dr. Das was formerly scientist at Efamol Research Institute, Kentville, Canada; Professor of Medicine at Nizam's Institute of Medical Sciences, Hyderabad, India and Research Professor of Surgery and Nutrition at SUNY (State University of New York) Upstate Medical University, Syracuse, USA. At present, he is the Chairman and Research Director of UND Life Sciences LLC, USA, and serves as a consultant to both Indian and USA based biotech and pharmaceutical companies. Undurti Das is the Founding Editor of the international journal: Lipids in Health and Disease; and serves on the editorial board of another 10 international journals. Dr Das has more than 500 international publications and has been awarded 5 USA patents.
